Clinical Trial Update: Dexmedetomidine and Propofol As Sole Sedative Agent for Patients Undergoing Arteriovenous Fistula Surgery [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update evaluating dexmedetomidine and propofol as the sole sedative regimen for patients undergoing arteriovenous fistula surge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriovenous Fistula

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• PROPOFOL (Propofol)

Snippet

Sponsor: Baskent University | Conditions: Arteriovenous Fistula | Phase 4 | Status: UNKNOWN